AXIM Biotechnologies (AXIM) News Today

→ The #1 Investment of the Decade… (From Porter & Company) (Ad)

$0.02

0.00 (0.00%)

(As of 04/15/2024 ET)

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Source

Source	Headline
	Axim youth appeal for sports infrastructure msn.com - April 4 at 4:22 PM
	VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024 globenewswire.com - March 27 at 9:00 AM
	We Want Peaceful Elections – Axim Youth msn.com - March 7 at 9:59 AM
	AXIM® Biotechnologies’ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation finance.yahoo.com - February 20 at 9:55 AM
	AXIM® Biotechnologies' Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation globenewswire.com - February 20 at 9:00 AM
	Axim Fishermen Hail Govt msn.com - February 7 at 11:05 AM
	MASLOC Trial: Daniel Axim Denies Charges msn.com - February 6 at 1:24 PM
	AXIM and Auer partner for dry eye disease assay production msn.com - December 21 at 1:37 PM
	AXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production finance.yahoo.com - December 20 at 2:01 PM
	Tullow builds 14-unit dormitory block for Axim Girls SHS msn.com - December 11 at 10:19 AM
	LLBO Lifeline Biotechnologies, Inc. seekingalpha.com - December 2 at 12:41 AM
	CollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Call Transcript seekingalpha.com - December 2 at 12:41 AM
	Court Orders Mental Test For Axim In MASLOC Trial msn.com - November 8 at 8:25 AM
	Axim Fishermen Plead For More Premix msn.com - November 1 at 1:07 PM
	AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson's Disease stockhouse.com - September 12 at 6:45 PM
	AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson’s Disease finance.yahoo.com - September 12 at 6:45 PM
	AXIM - AXIM Biotechnologies, Inc. finance.yahoo.com - September 10 at 6:02 PM
	AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test finance.yahoo.com - August 1 at 2:57 PM
	Update: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide finance.yahoo.com - July 12 at 6:47 PM
	Update: AXIM Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide finance.yahoo.com - July 12 at 6:47 PM
	AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide finance.yahoo.com - July 12 at 1:47 PM
	NV5's Newly Acquired Subsidiary Axim Pockets Contract From National Geospatial Intelligence Agency markets.businessinsider.com - June 14 at 3:03 PM
	AXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform Launch finance.yahoo.com - May 24 at 1:54 PM
	AXIM® Biotechnologies Appoints Kurt Phinney as Chief Operating Officer to Drive Scaling and Optimization of Manufacturing Unit finance.yahoo.com - May 23 at 9:35 AM
	iXCells Biotechnologies Expands CRISPR-Cas9 Cell Products and Genome Engineering Services businesswire.com - May 20 at 11:24 PM
	Vitiligo Drug Market Analysis and Growth Foresights till 2031 marketwatch.com - May 16 at 9:35 AM
	Axim Galamsey Gang Prime Suspect Arrested msn.com - April 23 at 8:18 PM
	AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays finance.yahoo.com - April 11 at 9:54 AM
	Nzema East MCE assures public of peace, tranquility in Axim msn.com - April 7 at 6:02 PM
	CollPlant Biotechnologies Ltd. (CLGN) Q4 2022 Earnings Call Transcript seekingalpha.com - March 31 at 9:37 AM
	Introducing Axim Collaborative and the Appointment of Stephanie Khurana as Chief Executive Officer technews.tmcnet.com - March 30 at 2:27 PM
	Axim Tartan Tracks Ready msn.com - March 29 at 8:11 PM
	Adaptive Biotechnologies Shares Cross Above 200 DMA nasdaq.com - March 29 at 10:10 AM
	Axim Youth Centre Almost Complete msn.com - March 22 at 9:45 PM
	Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion finance.yahoo.com - March 14 at 10:27 AM
	AXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical Diagnostic Assay Manufacturing finance.yahoo.com - March 14 at 10:27 AM
	AXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antibody Test, Applies for DEA License to Work With Controlled Substance finance.yahoo.com - January 17 at 2:57 PM
	AXIM® Biotechnologies CEO Issues Letter to Shareholders; Reminds of Conference Call finance.yahoo.com - January 11 at 10:09 AM
	AXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic Test; Files Provisional Patent finance.yahoo.com - December 13 at 3:36 PM
	AXIM Biotechnologies Commercial Partner Verséa Ophthalmics Highlights Benefits of AXIM’s Eye Diagnostic Solutions finance.yahoo.com - December 6 at 6:35 PM
	Chief Imam Storms Axim Hometown msn.com - December 5 at 3:22 PM
	Global Biotechnology / Pharmaceutical Services Outsourcing Market to Reach $86 Billion by 2027 finance.yahoo.com - November 12 at 2:08 PM
	AXIM(R) Biotechnologies Receives Initial Order for Diagnostic Solutions as Exclusive Partner Versea Ophthalmics Commences Initial Commercial Launch marketwatch.com - October 6 at 9:22 AM
	AXIM® Biotechnologies Receives Initial Order for Diagnostic Solutions as Exclusive Partner Verséa Ophthalmics Commences Initial Commercial Launch finance.yahoo.com - October 4 at 12:17 PM
	AXIM® Biotechnologies Point-of-Care Diagnostic Test Platform Sales Commence With Verséa Ophthalmics’ Commercial Launch at AAO 2022 finance.yahoo.com - September 29 at 10:48 AM
	AXIM® Biotechnologies Signs Exclusive Global Commercialization Agreement With Verséa™ Ophthalmics for Distribution and Sales of Novel Ophthalmic Diagnostics Solutions finance.yahoo.com - September 19 at 11:17 AM
	Axim Mini-Habour 85% Complete msn.com - September 12 at 11:54 AM
	Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region finance.yahoo.com - September 8 at 10:08 AM
	Verséa Holdings, Inc. welcomes Rob Sambursky, MD, as President to lead the company’s expansion into the ophthalmic market finance.yahoo.com - August 16 at 4:45 PM
	Axim Biotechnologies (OTC:AXIM), Analyst Ratings, Price Targets, Predictions benzinga.com - July 26 at 6:04 PM

Get AXIM Biotechnologies News Delivered to You Automatically

The #1 Investment of the Decade… (Ad)

Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.

To get all the details of this controversial tech – click here now.

AXIM Media Mentions By Week

AXIM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AXIM
News Sentiment
▼
0.00

0.66
▲
Average
Medical
News Sentiment

AXIM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AXIM Articles
This Week
▼
0

0
▲
AXIM Articles
Average Week

Get AXIM Biotechnologies News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (OTCMKTS:AXIM) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

AXIM Biotechnologies (AXIM) News Today

AXIM Media Mentions By Week

AXIM Media Sentiment

AXIM News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info